Inicio / Gastroenterología / Abstracts de gastroenterología / Faecal microbiota transplanta…

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

0 / 5 (0 votos)
Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

The Lancet Gastroenterology & Hepatology

Fecha de publicación: 17 July 2019

DOI: https://doi.org/10.1016/S2468-1253(19)30198-0

Autores: Olga C Aroniadis, MD., Prof Lawrence J Brandt, MD., Caterina Oneto, MD., Paul Feuerstadt, MD., Alex Sherman, MD., Prof Allan W Wolkoff, MD., et al.

Background: Faecal microbiota transplantation (FMT) has shown promise in alleviating the symptoms of irritable bowel syndrome (IBS); however, controlled data on this technique are scarce. The aim of this clinical trial was to assess the efficacy of FMT in alleviating diarrhoea-predominant IBS (IBS-D).

Leer más

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.